Brief: Targovax, Valo Therapeutics Enter Collaboration To Develop RAS

Circio Holding ASA

22/04/2020 06:07

April 22 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX AND VALO THERAPEUTICS ENTER COLLABORATION TO DEVELOP RAS
    * COLLABORATION COULD LEAD TO FURTHER DEVELOPMENT OF A FIRST-IN-CLASS MUTANT-RAS TARGETING
ONCOLYTIC VIRUS

Source text for Eikon:  ID:nObi6SVF4a 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))